Application Information

Application Number : 2024/006348

Application Date : 29-01-2018

Application Type : EPC Fasikül

Grant Number : 2024-GE-357930

Grant Date : 22-05-2024

Registration Number : 2024 006348

Registration Date : 2024-06-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3577125B1

European Patent Application Number : EP18705239.4

Applicants

Person No	Name	Address
7697032	GILEAD SCIENCES, INC.	333 LAKESIDE DRIVE FOSTER CITY, CA 94404 A.B.D.

Inventors

Person No	Name	Address
7697029	Chiajen LAI	C/O GILEAD SCIENCES INC. 333 LAKESIDE DRIVE FOSTER CITY, CA 94404 A.B.D.
7697031	G Robert STRICKLEY	1399 PARROTT DRIVE SAN MATEO, CA 94402 A.B.D.
7697030	Bing SHI	C/O GILEAD SCIENCES INC. 333 LAKESIDE DRIVE FOSTER CITY, CA 94404 A.B.D.

Invention Information

Name Of Invention	Tenofovir alafenamidin kristalli formları.
Summary Of Invention	Mevcut buluş, tenofovir alafenamid tuzlarının ve/veya ko-kristallerinin yeni kristalli formları, farmasötik formülasyonları ve bunların viral enfeksiyonların tedavisinde terapötik kullanımlarına yöneliktir.

Attorney Information

Name	FULYA SÜMERALP SİMAJ PATENT DAN. LTD. ŞTİ.
Address	HEKİMKÖY SİTESİ 1933 SOK.NO:8 - ÜMİTKÖY/ ANKARA

Priority Information

Date of Priority	Priority Number	Country of Priority
31-01-2017	US 201762452428P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
23-01-2025		Yıllık Ücret Ödeme Talebi
	27-05-2024	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
22-05-2024		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-06-2024	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
8	2025	23-01-2025	6920.0